arrow
K

Khê Hoang-Xuan

pitie-salpetriere hospital
H指数:83
被引数:3.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

CAR T-CELL THERAPY DOES NOT LEAD TO MEDIUM-TERM NEUROCOGNITIVE DETERIORATION IN PATIENTS WITH CENTRAL NERVOUS SYSTEM LYMPHOMAS. A LOC NETWORK STUDY

CAR T细胞疗法不会导致中枢神经系统淋巴瘤患者的中期神经认知功能恶化。一项LOC网络研究

2025-10-010
OAAI
B CAR T-CELL THERAPY IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMAS: A MULTICENTER RETROSPECTIVE STUDY FROM THE LOC NETWORK

B CAR T细胞疗法在原发性中枢神经系统淋巴瘤中的应用:LOC网络的多中心回顾性研究

2025-10-010
OA
Prognostic factors in adult patients with medulloblastoma

成人髓母细胞瘤患者的预后因素

2025-09-010
PRE
Tandem combination of ASCT and CAR T-cell therapy in highly refractory CNS lymphomas

ASCT与CAR T细胞疗法串联联合治疗高度难治性CNS淋巴瘤

2025-08-310
OAAI
Preliminary evidence of CAR T-cell therapy activity in vitreoretinal lymphomas: An LOC network study

CAR T细胞疗法在玻璃体视网膜淋巴瘤中的初步疗效证据:一项LOC网络研究

2025-08-250
OAAI
Gut microbiome modulates the outcome in primary central nervous system lymphoma patients undergoing chemotherapy: An ancillary study from the BLOCAGE trial

肠道微生物组调节接受化疗的原发性中枢神经系统淋巴瘤患者的结局:一项来自BLOCAGE试验的附加研究

2025-03-060
PRE
ICE polychemotherapy is an efficient salvage treatment in primary central nervous system lymphoma: an LOC network study

ICE联合化疗是原发性中枢神经系统淋巴瘤的有效挽救治疗方案:一项LOC网络研究

2025-02-040
OA
Unveiling the Clinical and Imaging Signatures of Intravascular Lymphoma of the Central Nervous System: A Multicentric Cohort Study
2024-11-280
PRE
RADIOTHERAPY VERSUS TMZ FOR HIGH-RISK LOW-GRADE GLIOMA. FINAL RESULTS AFTER MEDIAN FOLLOW-UP OF 13 YEARS OF PHASE III EORTC/NCIC-CTG/TROG/MRC-CTU (EORTC 22033-26033) STUDY
2024-11-110
PRE
Phase IB part of LOC-R01, a LOC network non-comparative randomized phase IB/II study testing R-MPV in combination with escalating doses of lenalidomide or ibrutinib for newly diagnosed primary central nervous system lymphoma (PCNSL) patients (vol 17, pg 86, 2024)
2024-10-190
OAAI